Osteopenic syndrome at diffuse-toxic goiter

Long -Term Outcome Therapy of Toxic Diffuse Goiter in Tehran

SUMMARY In order to evaluate the long-ter m effects of antithyroids and ahlative therapy on patients with toxic diffuse goiter (TDG) in an iodine deficient region, 206 patients were studied in Tehran. Hyperthyroidism recurred in 50%, of 80 patients treated with Methimazole (MMI), from one week to 48 months after cessation of therapy. Another 40 patients remained in remission. Of 102 patients t...

Iodinating activity of thyroid tissue in toxic diffuse goiter.

Thyroid tissue obtained from 12 patients with Graves' disease and treated with thionamide drugs for 3-7 mo before subtotal thyroidectomy, from 12 patients with Graves' disease, similarly treated, and given 50 mug of triiodothyronine (T3) for 10 days before surgery, and from 12 euthyroid patients with solitary cold nodules was investigated to compare in vitro iodination of thyroglobulin in toxic...

[Clinical biochemical and x-ray signs of a skeletal lesion in diffuse toxic goiter in children].

Direct Cost of Diffuse Toxic Goiter and Its Complications In Ukraine.

References Conclusion Methods Nowadays thyroid disease found in 50% of the adult population and 80% of the elderly population of Ukraine [1]. Growing prevalence of endocrine system disease (+9.11%) is an important medical and social problem in Ukraine. During the period 2006-2010 there was increase in the proportion of endocrine disease in total disease prevalence of 4.39% in 2006 to 4.43% in 2...

Thyroid cancer in toxic and non-toxic multinodular goiter.

BACKGROUND Many authors have claimed that hyperthyroidism protects against thyroid cancer and believed that the incidence of malignancy is lower in patients with toxic multinodular goiter (TMG) than in those with non-toxic multinodular goiter. But in recent studies, it was reported that the incidence of malignancy with TMG is not as low as previously thought. AIM To compare the thyroid cancer...